The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis-Reference-Cited by-同舟云学术

The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

Published:1994-05 Issue:5 Volume:19 Page:1149-1156
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Heathcote E. Jenny,Cauch-Dudek Karen,Walker Valery,Bailey Robert J.,Blendis Laurence M.,Ghent Cameron N.,Michieletti Pina,Minuk Gerald Y.,Pappas S. Chris,Scully Linda J.,Steinbrecher Urs P.,Sutherland Lloyd R.,Williams C. Noel,Witt-Sullivan Helga,Worobetz Lawrence J.,Milner Ruth A.,Wanless Ian R.

Publisher

Wiley

Subject

Hepatology

Reference37 articles.

1. Primary biliary cirrhosis: Paradigm or paradox for autoimmunity

2. Primary Biliary Cirrhosis: A Model Autoimmune Disease

3. A Prospective Controlled Trial of Azathioprine in Primary Biliary Cirrhosis

4. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis

5. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone loss

Cited by 310 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid;European Journal of Internal Medicine;2024-06

2. Pharmacotherapy for primary biliary cholangitis: an assessment of medication candidacy and rates of treatment;BMC Gastroenterology;2024-01-04

3. Akut lösemili çocukların idame tedavisinde kemoterapiye bağlı hepatotoksisite tedavisinde ursodeoksikolik asitin rolü;Family Practice and Palliative Care;2023-07-28

4. New Treatment Paradigms in Primary Biliary Cholangitis;Clinical Gastroenterology and Hepatology;2023-07

5. Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial;Hepatology Communications;2023-02-20